Ocular Involvement in Patients with Brucellosis: A Single-Center Prospective Study

References

• O’Callaghan D. Human brucellosis: recent advances and future challenges. Infect Dis Poverty. 2020;9(1):101. doi: 10.1186/s40249-020-00715-1.
   PubMed Web of Science ®Google Scholar
• Hull NC, Schumaker BA. Comparisons of brucellosis between human and veterinary medicine. Infect Ecol Epidemiol. 2018;8(1):1500846. doi: 10.1080/20008686.2018.1500846.
   PubMedGoogle Scholar
• Brucellosis. Brucellosis 2024. https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/brucellosis.
   Google Scholar
• D’Anastasio R, Staniscia T, Milia ML, Manzoli L, Capasso L. Origin, evolution and paleoepidemiology of brucellosis. Epidemiol Infect. 2011;139(1):149–156. doi: 10.1017/S095026881000097X.
   PubMed Web of Science ®Google Scholar
• Pappas G, Akritidis N, Bosilkovski M, Tsianos EB. Brucellosis. N Engl J Med. 2005;352(22):2325–2336. doi: 10.1056/NEJMra050570.
   PubMed Web of Science ®Google Scholar
• Corbel MJ. Brucellosis in humans and animals. https://www.who.int/publications/i/item/9789241547130. 2006. Accessed February 01, 2024.
   Google Scholar
• Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol. 2007;25(3):188–202. doi: 10.1016/S0255-0857(21)02105-8.
   PubMedGoogle Scholar
• Sahin O. Ocular manifestations of brucellosis [Internet]. Updates on brucellosis. 2015. doi: 10.5772/61475.
   Google Scholar
• Evlice O, Sa Ç, Filik A, Ağın A. Ocular involvement of brucellosis: a pooled analysis study. Ocul Immunol Inflamm. 2023;31(8):1677–1686. doi: 10.1080/09273948.2022.2164727.
   PubMed Web of Science ®Google Scholar
• Olut AI, Çayiröz MU, Özdemir ÖH, Yüce Yildirim D, Sönmez U, Karci G. Ocular brucellosis: case report and literature review. Mediterranean J Infect Microbes\ Antimicrobial. 2018. doi: 10.4274/mjima.2018.31.
   Google Scholar
• Sungur GK, Hazirolan D, Gurbuz Y, Unlu N, Duran S, Duman S. Ocular involvement in brucellosis. Can J Ophthalmol. 2009;44(5):598–601. doi: 10.3129/i09-019.
   PubMed Web of Science ®Google Scholar
• Rolando I, Olarte L, Vilchez G, Lluncor M, Otero L, Paris M, et al. Ocular manifestations associated with brucellosis: a 26-year experience in Peru. Clin Infect Dis. 2008;46(9):1338–1345. doi: 10.1086/529442.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Güngür K, Bekir NA, Namiduru M. Ocular complications associated with brucellosis in an endemic area. Eur J Ophthalmol. 2002;12(3):232–237. doi: 10.1177/112067210201200311.
   PubMed Web of Science ®Google Scholar
• Karakurt Y, Karakeçili F. Ophthalmological findings in brucellosis. J Fr Ophtalmol. 2023;46(7):769–775. doi: 10.1016/j.jfo.2023.02.017.
   PubMed Web of Science ®Google Scholar
• Walker J, Sharma OP, Rao NA. Brucellosis and uveitis. Am J Ophthalmol. 1992;114(3):374–375. doi: 10.1016/S0002-9394(14)71813-6.
   PubMed Web of Science ®Google Scholar
• Gómez MC, Nieto JA, Rosa C, Geijo P, Escribano MA, Muñoz A, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol. 2008;15(6):1031–1033. doi: 10.1128/CVI.00424-07.
   PubMed Web of Science ®Google Scholar
• Puig Solanes M, Heatley J, Arenas F, Guerrero Ibarra G. Ocular complications in brucellosis. Am J Ophthalmol. 1953;36(5):675–689. doi: 10.1016/0002-9394(53)90310-9.
   PubMed Web of Science ®Google Scholar
• Güngör K, Bekir NA, Namiduru M. Recurrent episcleritis associated with brucellosis. Acta Ophthalmol Scand. 2001;79(1):76–78. doi: 10.1034/j.1600-0420.2001.079001076.x.
   PubMedGoogle Scholar
• Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ. 2016;115(6):317–321.
   PubMedGoogle Scholar
• Lapić I, Padoan A, Bozzato D, Plebani M. Erythrocyte sedimentation rate and C-reactive protein in acute inflammation. Am J Clin Pathol. 2020;153(1):14–29. doi: 10.1093/ajcp/aqz142.
   PubMed Web of Science ®Google Scholar
• Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the lactate dehydrogenase assay. Cold Spring Harb Protoc. 2018;2018(6). doi: 10.1101/pdb.prot095497.
   Google Scholar
• Brigden ML. Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician. 1999;60(5):1443–1450.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang X, Chen X, Cui X, Cai M, Yang L, et al. Clinical features of human brucellosis and risk factors for focal complications: a retrospective analysis in a Tertiary-Care Hospital in Beijing, China. Int J Gen Med. 2022;15:7373–7382. doi: 10.2147/IJGM.S380328.
   PubMed Web of Science ®Google Scholar
• Sen P, Demirdal T, Nemli SA. Predictive value of inflammation markers in brucellosis. Arch Iran Med. 2019;22(11):640–645. doi: 10.4103/ijccm.IJCCM_308_18.
   PubMed Web of Science ®Google Scholar
• Demirdal T, Sen P. Risk factors for focal involvement in brucellosis. Diagn Microbiol Infect Dis. 2020;97(1):115003. doi: 10.1016/j.diagmicrobio.2020.115003.
   PubMed Web of Science ®Google Scholar
• Shi QN, Qin HJ, Lu QS, Li S, Tao ZF, Fan MG, et al. Incidence and warning signs for complications of human brucellosis: a multi-center observational study from China. Infect Dis Poverty. 2024;13(1):18. doi: 10.1186/s40249-024-01186-4.
   PubMed Web of Science ®Google Scholar
• Frenkel A, Shiloh A, Azulay B, Novack V, Klein M, Dreiher J, et al. The role of lactate dehydrogenase in hospitalized patients, comparing those with pulmonary versus non-pulmonary infections: a nationwide study. PLOS ONE. 2023;18(3):e0283380. doi: 10.1371/journal.pone.0283380.
   PubMed Web of Science ®Google Scholar
• Baldi PC, Giambartolomei GH. Immunopathology of Brucella infection. Recent Pat Antiinfect Drug Discov. 2013;8(1):18–26. doi: 10.2174/1574891X11308010005.
   PubMedGoogle Scholar
• Felek D, Çınar C. Investigation of brucellosis cases in and around Yozgat province. Ankyra Med J. 2023;2(3):89–94. doi: 10.51271/JTPM-0048.
   Google Scholar
• Shi C, Wang L, Lv D, Wang G, Mengist HM, Jin T, et al. Epidemiological, clinical and laboratory characteristics of patients with Brucella infection in Anhui Province, China. Infect Drug Resist. 2021;14:2741–2752. doi: 10.2147/IDR.S319595.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA. Therapeutic options for human brucellosis. Expert Rev Anti Infect Ther. 2008;6(1):109–120. doi: 10.1586/14787210.6.1.109.
   PubMed Web of Science ®Google Scholar
• Yumuk Z, O’Callaghan D. Brucellosis in Turkey – an overview. Int J Infect Dis. 2012;16(4):e228–35. doi: 10.1016/j.ijid.2011.12.011.
   PubMed Web of Science ®Google Scholar